仿單標示外使用
Sign in to saveAlso known as off-label drug use, extra-label drug use, off-label prescribing, off-label drug prescribing
use of pharmaceutical drugs or vaccines for an unapproved indication concerning the treatment of a particular disease or condition as designated by a regulatory agency
Research
19,653 papers- Off-label use of medicines in South Africa: a review.Orphanet journal of rare diseases · 2024
- Subcutaneous Drugs and Off-label Use in Hospice and Palliative Care: A Scoping Review.Journal of pain and symptom management · 2022
- Off-Label Use of Baricitinib in Dermatology.Journal of drugs in dermatology : JDD · 2023
- Off-label use of upadacitinib in dermatology: a review.The Journal of dermatological treatment · 2025
- Off-Label Use in Orthopaedic Surgery.The Journal of the American Academy of Orthopaedic Surgeons · 2019
via PubMed
Wikidata facts
- Subclass of
- medical prescription
Show 1 more fact
- different from
- drug repositioning
Sources (2)
via Wikidata · CC0
Article · 中文
仿單標示外使用(英語:off-label use,也可寫為標示外使用)指的是把藥物使用在未經核准的、年齡層、劑量、或給藥途徑。處方藥和非處方藥均可作標示外使用,但大多數對這種使用的研究都集中在處方藥上。 除非有違反道德準則或是違反安全規定,標示外使用常見,而且通常都屬合法。醫療衛生提供者開立藥物,用在超出官方核准的適應症,為的是用來產生療效。例如,因為氨甲蝶呤(在台灣,學名為胺基甲基葉酸,商品名為滅殺除癌錠,及治善錠)的免疫調節作用可為各種病症提供舒緩,而被廣泛使用.。但是,標示外使用可能會有健康風險,以及產生法律責任爭議。針對藥廠本身做藥物標示外使用的市場推廣,通常被禁止。
Abstract from DBpedia / Wikipedia · CC BY-SA
Available in 24 languages
- Español
- Deutsch
- 中文
- 日本語
- Русский
- Português
- Italiano
- العربية
- Bahasa Indonesia
- Catalan
- Central Kurdish
- Finnish
- Hebrew
- Hungarian
- Macedonian
- Nederlands
- Norwegian
- Polski
Show 5 more
via Wikidata sitelinks · CC0